speb/financial-data huggingface dataset:
ECG cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -5114000.00
ECG income_statement (quarterly, 2025-03-31) — Operating Income: 50984000.00
ECG income_statement (quarterly, 2025-03-31) — Operating Revenue: 833242000.00
ECG balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 50999228.00
ECG balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 34848000.00
ECG balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 15000000.00
ECG income_statement (quarterly, 2025-03-31) — Other Income Expense: 567000.00
ECG cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 394000.00
ECG balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 4609000.00
ECG balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 22904000.00
ECG income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: 567000.00
ECG balance_sheet (quarterly, 2025-03-31) — Other Properties: 375088000.00
ECG balance_sheet (quarterly, 2025-03-31) — Other Receivables: 227052000.00
ECG balance_sheet (quarterly, 2025-03-31) — Payables: 206843000.00
ECG balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 263742000.00
ECG balance_sheet (quarterly, 2025-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 52864000.00
ECG income_statement (quarterly, 2025-03-31) — Pretax Income: 46857000.00
ECG cash_flow (quarterly, 2025-03-31) — Provisionand Write Offof Assets: -1729000.00
ECG balance_sheet (quarterly, 2025-03-31) — Raw Materials: 7400000.00
ECG balance_sheet (quarterly, 2025-03-31) — Receivables: 814719000.00
ECG balance_sheet (quarterly, 2025-03-31) — Receivables Adjustments Allowances: -3064000.00
ECG income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 734136000.00
ECG income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 6890000.00
ECG cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -3750000.00
ECG balance_sheet (quarterly, 2025-03-31) — Restricted Cash: 19700000.00
ECG balance_sheet (quarterly, 2025-03-31) — Retained Earnings: 320644000.00
ECG cash_flow (quarterly, 2025-03-31) — Sale Of PPE: 3310000.00
ECG income_statement (quarterly, 2025-03-31) — Selling General And Administration: 41509000.00
ECG balance_sheet (quarterly, 2025-03-31) — Share Issued: 50999228.00
ECG cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1747000.00
ECG balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 460199000.00
ECG balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 316975000.00
ECG income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
ECG income_statement (quarterly, 2025-03-31) — Tax Provision: 13573000.00
ECG income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.29
ECG balance_sheet (quarterly, 2025-03-31) — Total Assets: 1355847000.00
ECG balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 737322000.00
ECG balance_sheet (quarterly, 2025-03-31) — Total Debt: 360358000.00
ECG balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 460199000.00
ECG income_statement (quarterly, 2025-03-31) — Total Expenses: 775645000.00
ECG balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 895648000.00
ECG balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 384880000.00
ECG balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 349709000.00
ECG income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: 50984000.00
ECG balance_sheet (quarterly, 2025-03-31) — Total Tax Payable: 24508000.00
ECG cash_flow (quarterly, 2025-03-31) — Unrealized Gain Loss On Investment Securities: 117000.00
ECG balance_sheet (quarterly, 2025-03-31) — Working Capital: 425028000.00
ECG income_statement (quarterly, 2025-06-30) — +Operating Expense: 47362000.00
ECG income_statement (quarterly, 2025-06-30) — +Total Revenue: 921466000.00
ECG balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 199091000.00
ECG balance_sheet (quarterly, 2025-06-30) — Accounts Receivable: 682744000.00
ECG balance_sheet (quarterly, 2025-06-30) — Accumulated Depreciation: -165888000.00
ECG balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 140412000.00
ECG cash_flow (quarterly, 2025-06-30) — Amortization Cash Flow: 0.00
ECG cash_flow (quarterly, 2025-06-30) — Amortization Of Intangibles: 0.00
ECG income_statement (quarterly, 2025-06-30) — Basic Average Shares: 51041000.00
ECG income_statement (quarterly, 2025-06-30) — Basic EPS: 1.04
ECG cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 73981000.00
ECG cash_flow (quarterly, 2025-06-30) — Capital Expenditure: -13084000.00
ECG cash_flow (quarterly, 2025-06-30) — Capital Expenditure Reported: -13084000.00
ECG balance_sheet (quarterly, 2025-06-30) — Capital Lease Obligations: 74409000.00
ECG balance_sheet (quarterly, 2025-06-30) — Capital Stock: 510000.00
ECG balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 64508000.00
ECG balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 64508000.00
ECG cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: -3750000.00
ECG cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: -10865000.00
ECG cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: 25342000.00
ECG cash_flow (quarterly, 2025-06-30) — Change In Account Payable: 16922000.00
ECG cash_flow (quarterly, 2025-06-30) — Change In Inventory: -639000.00
ECG cash_flow (quarterly, 2025-06-30) — Change In Other Current Assets: 6041000.00
ECG cash_flow (quarterly, 2025-06-30) — Change In Other Current Liabilities: 6689000.00
ECG cash_flow (quarterly, 2025-06-30) — Change In Other Working Capital: 44395000.00
ECG cash_flow (quarterly, 2025-06-30) — Change In Payable: 16922000.00
ECG cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 16922000.00
ECG cash_flow (quarterly, 2025-06-30) — Change In Receivables: -112734000.00
ECG cash_flow (quarterly, 2025-06-30) — Change In Working Capital: -39326000.00
ECG cash_flow (quarterly, 2025-06-30) — Changes In Account Receivables: -90142000.00
ECG cash_flow (quarterly, 2025-06-30) — Changes In Cash: 10727000.00
ECG balance_sheet (quarterly, 2025-06-30) — Common Stock: 510000.00
ECG balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 514409000.00
ECG income_statement (quarterly, 2025-06-30) — Cost Of Revenue: 801597000.00
ECG balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 56639000.00
ECG balance_sheet (quarterly, 2025-06-30) — Current Assets: 1089026000.00
ECG balance_sheet (quarterly, 2025-06-30) — Current Capital Lease Obligation: 28909000.00
ECG balance_sheet (quarterly, 2025-06-30) — Current Debt: 15000000.00
ECG balance_sheet (quarterly, 2025-06-30) — Current Debt And Capital Lease Obligation: 43909000.00
ECG balance_sheet (quarterly, 2025-06-30) — Current Deferred Liabilities: 230354000.00
ECG balance_sheet (quarterly, 2025-06-30) — Current Deferred Revenue: 230354000.00
ECG balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 614314000.00
ECG cash_flow (quarterly, 2025-06-30) — Deferred Income Tax: 1257000.00
ECG cash_flow (quarterly, 2025-06-30) — Deferred Tax: 1257000.00
ECG cash_flow (quarterly, 2025-06-30) — Depreciation: 7127000.00
ECG cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 7127000.00
ECG cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 7127000.00
ECG income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 51094000.00
ECG income_statement (quarterly, 2025-06-30) — Diluted EPS: 1.03
ECG income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: 52843000.00
ECG income_statement (quarterly, 2025-06-30) — EBIT: 74415000.00
ECG income_statement (quarterly, 2025-06-30) — EBITDA: 81542000.00
ECG income_statement (quarterly, 2025-06-30) — Earnings From Equity Interest Net Of Tax: 2649000.00
ECG cash_flow (quarterly, 2025-06-30) — Earnings Losses From Equity Investments: 3652000.00
ECG cash_flow (quarterly, 2025-06-30) — End Cash Position: 84708000.00
ECG cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: -3750000.00
ECG balance_sheet (quarterly, 2025-06-30) — Finished Goods: 41400000.00
ECG cash_flow (quarterly, 2025-06-30) — Free Cash Flow: 12258000.00
ECG balance_sheet (quarterly, 2025-06-30) — Goodwill: 143224000.00
ECG balance_sheet (quarterly, 2025-06-30) — Goodwill And Other Intangible Assets: 143224000.00
ECG balance_sheet (quarterly, 2025-06-30) — Gross PPE: 390039000.00
ECG income_statement (quarterly, 2025-06-30) — Gross Profit: 119869000.00
ECG cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 28537000.00
ECG income_statement (quarterly, 2025-06-30) — Interest Expense: 4813000.00
ECG income_statement (quarterly, 2025-06-30) — Interest Expense Non Operating: 4813000.00
ECG cash_flow (quarterly, 2025-06-30) — Interest Paid Supplemental Data: 5972000.00
ECG balance_sheet (quarterly, 2025-06-30) — Inventory: 48000000.00
ECG balance_sheet (quarterly, 2025-06-30) — Invested Capital: 803008000.00
ECG cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: -10865000.00
ECG balance_sheet (quarterly, 2025-06-30) — Investments And Advances: 20375000.00
ECG balance_sheet (quarterly, 2025-06-30) — Long Term Capital Lease Obligation: 45500000.00
ECG balance_sheet (quarterly, 2025-06-30) — Long Term Debt: 273599000.00
ECG balance_sheet (quarterly, 2025-06-30) — Long Term Debt And Capital Lease Obligation: 319099000.00
ECG cash_flow (quarterly, 2025-06-30) — Long Term Debt Payments: -3750000.00
ECG balance_sheet (quarterly, 2025-06-30) — Net Debt: 224091000.00
ECG income_statement (quarterly, 2025-06-30) — Net Income: 52843000.00
ECG income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: 52843000.00
ECG income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: 52843000.00
ECG income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: 52843000.00
ECG income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: 52843000.00
ECG cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: 52843000.00
ECG income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: 52843000.00
ECG income_statement (quarterly, 2025-06-30) — Net Interest Income: -4813000.00
ECG cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: -106000.00
ECG cash_flow (quarterly, 2025-06-30) — Net Issuance Payments Of Debt: -3750000.00
ECG cash_flow (quarterly, 2025-06-30) — Net Long Term Debt Issuance: -3750000.00
ECG income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: -4813000.00
ECG cash_flow (quarterly, 2025-06-30) — Net Other Financing Charges: 0.00
ECG cash_flow (quarterly, 2025-06-30) — Net Other Investing Changes: 0.00
ECG balance_sheet (quarterly, 2025-06-30) — Net PPE: 224151000.00
ECG cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: 2325000.00
ECG balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 371185000.00
ECG balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Liabilities: 10834000.00
ECG balance_sheet (quarterly, 2025-06-30) — Non Current Deferred Taxes Liabilities: 10834000.00
ECG income_statement (quarterly, 2025-06-30) — Normalized EBITDA: 81542000.00
ECG income_statement (quarterly, 2025-06-30) — Normalized Income: 52843000.00
ECG cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: 25342000.00
ECG cash_flow (quarterly, 2025-06-30) — Operating Gains Losses: 2341000.00
ECG income_statement (quarterly, 2025-06-30) — Operating Income: 72507000.00
ECG income_statement (quarterly, 2025-06-30) — Operating Revenue: 925984000.00
ECG balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 51006575.00
ECG balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 28865000.00
ECG balance_sheet (quarterly, 2025-06-30) — Other Current Borrowings: 15000000.00
ECG income_statement (quarterly, 2025-06-30) — Other Income Expense: 1908000.00
ECG cash_flow (quarterly, 2025-06-30) — Other Non Cash Items: 394000.00
ECG balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 4601000.00
ECG balance_sheet (quarterly, 2025-06-30) — Other Non Current Liabilities: 22721000.00
ECG income_statement (quarterly, 2025-06-30) — Other Non Operating Income Expenses: 1908000.00
ECG balance_sheet (quarterly, 2025-06-30) — Other Properties: 390039000.00
ECG balance_sheet (quarterly, 2025-06-30) — Other Receivables: 247715000.00
ECG balance_sheet (quarterly, 2025-06-30) — Payables: 209372000.00
ECG balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 266011000.00
ECG balance_sheet (quarterly, 2025-06-30) — Pensionand Other Post Retirement Benefit Plans Current: 74040000.00
ECG income_statement (quarterly, 2025-06-30) — Pretax Income: 69602000.00
ECG cash_flow (quarterly, 2025-06-30) — Provisionand Write Offof Assets: 0.00
ECG balance_sheet (quarterly, 2025-06-30) — Raw Materials: 6600000.00
ECG balance_sheet (quarterly, 2025-06-30) — Receivables: 927453000.00
ECG balance_sheet (quarterly, 2025-06-30) — Receivables Adjustments Allowances: -3006000.00
ECG income_statement (quarterly, 2025-06-30) — Reconciled Cost Of Revenue: 801597000.00
ECG income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 7127000.00
ECG cash_flow (quarterly, 2025-06-30) — Repayment Of Debt: -3750000.00
ECG balance_sheet (quarterly, 2025-06-30) — Restricted Cash: 20200000.00
ECG balance_sheet (quarterly, 2025-06-30) — Retained Earnings: 373487000.00
ECG cash_flow (quarterly, 2025-06-30) — Sale Of PPE: 2325000.00
ECG income_statement (quarterly, 2025-06-30) — Selling General And Administration: 47362000.00
ECG balance_sheet (quarterly, 2025-06-30) — Share Issued: 51006575.00
ECG cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1123000.00
ECG balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 514409000.00
ECG balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 371185000.00
ECG income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
ECG income_statement (quarterly, 2025-06-30) — Tax Provision: 19408000.00
ECG income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.27
ECG balance_sheet (quarterly, 2025-06-30) — Total Assets: 1481377000.00
ECG balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 788008000.00
ECG balance_sheet (quarterly, 2025-06-30) — Total Debt: 363008000.00
ECG balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 514409000.00
ECG income_statement (quarterly, 2025-06-30) — Total Expenses: 848959000.00
ECG balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 966968000.00
ECG balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 392351000.00
ECG balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 352654000.00
ECG income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: 72507000.00
ECG balance_sheet (quarterly, 2025-06-30) — Total Tax Payable: 10281000.00
ECG cash_flow (quarterly, 2025-06-30) — Unrealized Gain Loss On Investment Securities: -417000.00
ECG balance_sheet (quarterly, 2025-06-30) — Working Capital: 474712000.00
ECG income_statement (quarterly, 2025-09-30) — +Operating Expense: 51841000.00
ECG income_statement (quarterly, 2025-09-30) — +Total Revenue: 986820000.00
ECG balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 213055000.00
ECG balance_sheet (quarterly, 2025-09-30) — Accounts Receivable: 739366000.00
ECG balance_sheet (quarterly, 2025-09-30) — Accumulated Depreciation: -170975000.00
ECG balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 142072000.00
ECG cash_flow (quarterly, 2025-09-30) — Amortization Cash Flow: 0.00
ECG cash_flow (quarterly, 2025-09-30) — Amortization Of Intangibles: 0.00
ECG income_statement (quarterly, 2025-09-30) — Basic Average Shares: 51048000.00
ECG income_statement (quarterly, 2025-09-30) — Basic EPS: 1.12
ECG cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 84708000.00
ECG cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -10496000.00
ECG cash_flow (quarterly, 2025-09-30) — Capital Expenditure Reported: -10496000.00
ECG balance_sheet (quarterly, 2025-09-30) — Capital Lease Obligations: 84509000.00
ECG balance_sheet (quarterly, 2025-09-30) — Capital Stock: 510000.00
ECG balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 129867000.00
ECG balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 129867000.00
ECG cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: -3750000.00
ECG cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: -7961000.00
ECG cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: 76170000.00
ECG cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 14529000.00
ECG cash_flow (quarterly, 2025-09-30) — Change In Inventory: 95000.00
ECG cash_flow (quarterly, 2025-09-30) — Change In Other Current Assets: 4758000.00
ECG cash_flow (quarterly, 2025-09-30) — Change In Other Current Liabilities: 22074000.00
ECG cash_flow (quarterly, 2025-09-30) — Change In Other Working Capital: 40017000.00
ECG cash_flow (quarterly, 2025-09-30) — Change In Payable: 14529000.00
ECG cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 14529000.00
ECG cash_flow (quarterly, 2025-09-30) — Change In Receivables: -66977000.00
ECG cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 14496000.00
ECG cash_flow (quarterly, 2025-09-30) — Changes In Account Receivables: -61002000.00
ECG cash_flow (quarterly, 2025-09-30) — Changes In Cash: 64459000.00
ECG balance_sheet (quarterly, 2025-09-30) — Common Stock: 510000.00
ECG balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 573046000.00
ECG income_statement (quarterly, 2025-09-30) — Cost Of Revenue: 862598000.00
ECG balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 53839000.00
ECG balance_sheet (quarterly, 2025-09-30) — Current Assets: 1215391000.00
ECG balance_sheet (quarterly, 2025-09-30) — Current Capital Lease Obligation: 30933000.00
ECG balance_sheet (quarterly, 2025-09-30) — Current Debt: 15000000.00
ECG balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 45933000.00
ECG balance_sheet (quarterly, 2025-09-30) — Current Deferred Liabilities: 269832000.00
ECG balance_sheet (quarterly, 2025-09-30) — Current Deferred Revenue: 269832000.00
ECG balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 691854000.00
ECG cash_flow (quarterly, 2025-09-30) — Deferred Income Tax: 1606000.00
ECG cash_flow (quarterly, 2025-09-30) — Deferred Tax: 1606000.00
ECG cash_flow (quarterly, 2025-09-30) — Depreciation: 7292000.00
ECG cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 7292000.00
ECG cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 7292000.00
ECG income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 51137000.00
ECG income_statement (quarterly, 2025-09-30) — Diluted EPS: 1.11
ECG income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: 56977000.00
ECG income_statement (quarterly, 2025-09-30) — EBIT: 77495000.00
ECG income_statement (quarterly, 2025-09-30) — EBITDA: 84787000.00
ECG income_statement (quarterly, 2025-09-30) — Earnings From Equity Interest Net Of Tax: 5540000.00
ECG cash_flow (quarterly, 2025-09-30) — Earnings Losses From Equity Investments: -5000000.00
ECG cash_flow (quarterly, 2025-09-30) — End Cash Position: 149167000.00
ECG cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: -3750000.00
ECG balance_sheet (quarterly, 2025-09-30) — Finished Goods: 28453000.00
ECG cash_flow (quarterly, 2025-09-30) — Free Cash Flow: 65674000.00
ECG balance_sheet (quarterly, 2025-09-30) — Goodwill: 143224000.00
ECG balance_sheet (quarterly, 2025-09-30) — Goodwill And Other Intangible Assets: 143224000.00
ECG balance_sheet (quarterly, 2025-09-30) — Gross PPE: 405943000.00
ECG income_statement (quarterly, 2025-09-30) — Gross Profit: 124222000.00
ECG cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 16547000.00
ECG income_statement (quarterly, 2025-09-30) — Interest Expense: 5441000.00
ECG income_statement (quarterly, 2025-09-30) — Interest Expense Non Operating: 5441000.00
ECG income_statement (quarterly, 2025-09-30) — Interest Income: 1369000.00
ECG income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 1369000.00
ECG cash_flow (quarterly, 2025-09-30) — Interest Paid Supplemental Data: 4940000.00
ECG balance_sheet (quarterly, 2025-09-30) — Inventories Adjustments Allowances: -587000.00
ECG balance_sheet (quarterly, 2025-09-30) — Inventory: 47957000.00
ECG balance_sheet (quarterly, 2025-09-30) — Invested Capital: 858120000.00
ECG cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: -7961000.00
ECG balance_sheet (quarterly, 2025-09-30) — Investments And Advances: 25740000.00
ECG balance_sheet (quarterly, 2025-09-30) — Long Term Capital Lease Obligation: 53576000.00
ECG balance_sheet (quarterly, 2025-09-30) — Long Term Debt: 270074000.00
ECG balance_sheet (quarterly, 2025-09-30) — Long Term Debt And Capital Lease Obligation: 323650000.00
ECG cash_flow (quarterly, 2025-09-30) — Long Term Debt Payments: -3750000.00
ECG balance_sheet (quarterly, 2025-09-30) — Net Debt: 155207000.00
ECG income_statement (quarterly, 2025-09-30) — Net Income: 56977000.00
ECG income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: 56977000.00
ECG income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: 56977000.00
ECG income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: 56977000.00
ECG income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: 56977000.00
ECG cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: 56977000.00
ECG income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: 56977000.00
ECG income_statement (quarterly, 2025-09-30) — Net Interest Income: -4072000.00
ECG cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: -99000.00
ECG cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: -3750000.00
ECG cash_flow (quarterly, 2025-09-30) — Net Long Term Debt Issuance: -3750000.00
ECG income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: -4072000.00
ECG cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: 0.00
ECG cash_flow (quarterly, 2025-09-30) — Net Other Investing Changes: 0.00
ECG balance_sheet (quarterly, 2025-09-30) — Net PPE: 234968000.00
ECG cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: 2634000.00
ECG balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 429822000.00
ECG balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Liabilities: 12440000.00
ECG balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Taxes Liabilities: 12440000.00
ECG income_statement (quarterly, 2025-09-30) — Normalized EBITDA: 84787000.00
ECG income_statement (quarterly, 2025-09-30) — Normalized Income: 56977000.00
ECG cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: 76170000.00
ECG cash_flow (quarterly, 2025-09-30) — Operating Gains Losses: -6465000.00
ECG income_statement (quarterly, 2025-09-30) — Operating Income: 72381000.00
ECG income_statement (quarterly, 2025-09-30) — Operating Revenue: 990724000.00
ECG balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 51006575.00
ECG balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 24055000.00
ECG balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 15000000.00
ECG income_statement (quarterly, 2025-09-30) — Other Income Expense: 3745000.00
ECG cash_flow (quarterly, 2025-09-30) — Other Non Cash Items: 394000.00
ECG balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 4413000.00
ECG balance_sheet (quarterly, 2025-09-30) — Other Non Current Liabilities: 22746000.00
ECG income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: 3745000.00
ECG balance_sheet (quarterly, 2025-09-30) — Other Properties: 405943000.00
ECG balance_sheet (quarterly, 2025-09-30) — Other Receivables: 258038000.00
ECG balance_sheet (quarterly, 2025-09-30) — Payables: 224811000.00
ECG balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 278650000.00
ECG balance_sheet (quarterly, 2025-09-30) — Pensionand Other Post Retirement Benefit Plans Current: 97439000.00
ECG balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
ECG income_statement (quarterly, 2025-09-30) — Pretax Income: 72054000.00
ECG cash_flow (quarterly, 2025-09-30) — Provisionand Write Offof Assets: 218000.00
ECG balance_sheet (quarterly, 2025-09-30) — Raw Materials: 15567000.00
ECG balance_sheet (quarterly, 2025-09-30) — Receivables: 994212000.00
ECG balance_sheet (quarterly, 2025-09-30) — Receivables Adjustments Allowances: -3192000.00
ECG income_statement (quarterly, 2025-09-30) — Reconciled Cost Of Revenue: 862598000.00
ECG income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 7292000.00
ECG cash_flow (quarterly, 2025-09-30) — Repayment Of Debt: -3750000.00
ECG balance_sheet (quarterly, 2025-09-30) — Restricted Cash: 19300000.00
ECG balance_sheet (quarterly, 2025-09-30) — Retained Earnings: 430464000.00
ECG cash_flow (quarterly, 2025-09-30) — Sale Of PPE: 2634000.00
ECG income_statement (quarterly, 2025-09-30) — Selling General And Administration: 51841000.00
ECG balance_sheet (quarterly, 2025-09-30) — Share Issued: 51006575.00
ECG cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1918000.00
ECG balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 573046000.00
ECG balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 429822000.00
ECG income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
ECG income_statement (quarterly, 2025-09-30) — Tax Provision: 20617000.00
ECG income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.27
ECG balance_sheet (quarterly, 2025-09-30) — Total Assets: 1623736000.00
ECG balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 843120000.00
ECG balance_sheet (quarterly, 2025-09-30) — Total Debt: 369583000.00
ECG balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 573046000.00
ECG income_statement (quarterly, 2025-09-30) — Total Expenses: 914439000.00
ECG balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 1050690000.00
ECG balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 408345000.00
ECG balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 358836000.00
ECG income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: 72381000.00
ECG balance_sheet (quarterly, 2025-09-30) — Total Tax Payable: 11756000.00
ECG cash_flow (quarterly, 2025-09-30) — Unrealized Gain Loss On Investment Securities: -266000.00
ECG balance_sheet (quarterly, 2025-09-30) — Work In Process: 4524000.00
ECG balance_sheet (quarterly, 2025-09-30) — Working Capital: 523537000.00
ECG income_statement (annual, 2025-12-31) — +Operating Expense: 189338000.00
ECG income_statement (quarterly, 2025-12-31) — +Operating Expense: 48626000.00
ECG income_statement (annual, 2025-12-31) — +Total Revenue: 3746387000.00
ECG income_statement (quarterly, 2025-12-31) — +Total Revenue: 1011472000.00
ECG balance_sheet (annual, 2025-12-31) — Accounts Payable: 226264000.00
ECG balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 226264000.00
ECG balance_sheet (annual, 2025-12-31) — Accounts Receivable: 769010000.00
ECG balance_sheet (quarterly, 2025-12-31) — Accounts Receivable: 769010000.00
ECG balance_sheet (annual, 2025-12-31) — Accumulated Depreciation: -174914000.00
ECG balance_sheet (quarterly, 2025-12-31) — Accumulated Depreciation: -174914000.00
ECG balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 143566000.00
ECG balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 143566000.00
ECG cash_flow (annual, 2025-12-31) — Amortization Cash Flow: 116000.00
ECG cash_flow (quarterly, 2025-12-31) — Amortization Cash Flow: 0.00
ECG cash_flow (annual, 2025-12-31) — Amortization Of Intangibles: 116000.00
ECG cash_flow (quarterly, 2025-12-31) — Amortization Of Intangibles: 0.00
ECG income_statement (annual, 2025-12-31) — Basic Average Shares: 51045000.00
ECG income_statement (quarterly, 2025-12-31) — Basic Average Shares: 51051000.00
ECG income_statement (annual, 2025-12-31) — Basic EPS: 3.95
ECG income_statement (quarterly, 2025-12-31) — Basic EPS: 1.08
ECG cash_flow (annual, 2025-12-31) — Beginning Cash Position: 86012000.00
ECG cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 149167000.00
ECG balance_sheet (annual, 2025-12-31) — Buildings And Improvements: 65117000.00
ECG balance_sheet (quarterly, 2025-12-31) — Buildings And Improvements: 65117000.00
ECG cash_flow (annual, 2025-12-31) — Capital Expenditure: -66836000.00
ECG cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -24717000.00
ECG cash_flow (annual, 2025-12-31) — Capital Expenditure Reported: -66836000.00
ECG cash_flow (quarterly, 2025-12-31) — Capital Expenditure Reported: -24717000.00
ECG balance_sheet (annual, 2025-12-31) — Capital Lease Obligations: 90539000.00
ECG balance_sheet (quarterly, 2025-12-31) — Capital Lease Obligations: 90539000.00
ECG balance_sheet (annual, 2025-12-31) — Capital Stock: 510000.00
ECG balance_sheet (quarterly, 2025-12-31) — Capital Stock: 510000.00
ECG balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 170500000.00
ECG balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 170500000.00
ECG balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 170500000.00
ECG balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 170500000.00
ECG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: -15588000.00
ECG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: -3750000.00
ECG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -56769000.00
ECG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -23122000.00
ECG cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: 156845000.00
ECG cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: 48205000.00
ECG cash_flow (annual, 2025-12-31) — Change In Account Payable: 88372000.00
ECG cash_flow (quarterly, 2025-12-31) — Change In Account Payable: 13296000.00
ECG cash_flow (annual, 2025-12-31) — Change In Inventory: -1521000.00
ECG cash_flow (quarterly, 2025-12-31) — Change In Inventory: 2686000.00
ECG cash_flow (annual, 2025-12-31) — Change In Other Current Assets: -24625000.00
ECG cash_flow (quarterly, 2025-12-31) — Change In Other Current Assets: -30960000.00
ECG cash_flow (annual, 2025-12-31) — Change In Other Current Liabilities: 29218000.00
ECG cash_flow (quarterly, 2025-12-31) — Change In Other Current Liabilities: -7124000.00
ECG cash_flow (annual, 2025-12-31) — Change In Other Working Capital: 101054000.00
ECG cash_flow (quarterly, 2025-12-31) — Change In Other Working Capital: 36703000.00
ECG cash_flow (annual, 2025-12-31) — Change In Payable: 88372000.00
ECG cash_flow (quarterly, 2025-12-31) — Change In Payable: 13296000.00
ECG cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 88372000.00
ECG cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 13296000.00
ECG cash_flow (annual, 2025-12-31) — Change In Receivables: -269154000.00
ECG cash_flow (quarterly, 2025-12-31) — Change In Receivables: -33530000.00
ECG cash_flow (annual, 2025-12-31) — Change In Working Capital: -76656000.00
ECG cash_flow (quarterly, 2025-12-31) — Change In Working Capital: -18929000.00
ECG cash_flow (annual, 2025-12-31) — Changes In Account Receivables: -180436000.00
ECG cash_flow (quarterly, 2025-12-31) — Changes In Account Receivables: -28240000.00
ECG cash_flow (annual, 2025-12-31) — Changes In Cash: 84488000.00
ECG cash_flow (quarterly, 2025-12-31) — Changes In Cash: 21333000.00
ECG balance_sheet (annual, 2025-12-31) — Common Stock: 510000.00
ECG balance_sheet (quarterly, 2025-12-31) — Common Stock: 510000.00
ECG balance_sheet (annual, 2025-12-31) — Common Stock Equity: 629818000.00
ECG balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 629818000.00
ECG income_statement (annual, 2025-12-31) — Cost Of Revenue: 3292299000.00
ECG income_statement (quarterly, 2025-12-31) — Cost Of Revenue: 893968000.00
ECG balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 62467000.00
ECG balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 62467000.00
ECG balance_sheet (annual, 2025-12-31) — Current Assets: 1296381000.00
ECG balance_sheet (quarterly, 2025-12-31) — Current Assets: 1296381000.00
ECG balance_sheet (annual, 2025-12-31) — Current Capital Lease Obligation: 33905000.00
ECG balance_sheet (quarterly, 2025-12-31) — Current Capital Lease Obligation: 33905000.00
ECG balance_sheet (annual, 2025-12-31) — Current Debt: 15000000.00
ECG balance_sheet (quarterly, 2025-12-31) — Current Debt: 15000000.00
ECG balance_sheet (annual, 2025-12-31) — Current Debt And Capital Lease Obligation: 48905000.00
ECG balance_sheet (quarterly, 2025-12-31) — Current Debt And Capital Lease Obligation: 48905000.00
ECG balance_sheet (annual, 2025-12-31) — Current Deferred Liabilities: 305111000.00
ECG balance_sheet (quarterly, 2025-12-31) — Current Deferred Liabilities: 305111000.00
ECG balance_sheet (annual, 2025-12-31) — Current Deferred Revenue: 305111000.00
ECG balance_sheet (quarterly, 2025-12-31) — Current Deferred Revenue: 305111000.00
ECG balance_sheet (annual, 2025-12-31) — Current Liabilities: 736190000.00
ECG balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 736190000.00
ECG cash_flow (annual, 2025-12-31) — Deferred Income Tax: 6341000.00
ECG cash_flow (quarterly, 2025-12-31) — Deferred Income Tax: 2430000.00
ECG cash_flow (annual, 2025-12-31) — Deferred Tax: 6341000.00
ECG cash_flow (quarterly, 2025-12-31) — Deferred Tax: 2430000.00
ECG cash_flow (annual, 2025-12-31) — Depreciation: 28684000.00
ECG cash_flow (quarterly, 2025-12-31) — Depreciation: 7491000.00
ECG cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 28800000.00
ECG cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 7491000.00
ECG cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 28800000.00
ECG cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 7491000.00
ECG income_statement (annual, 2025-12-31) — Diluted Average Shares: 51123000.00
ECG income_statement (quarterly, 2025-12-31) — Diluted Average Shares: 51168000.00
ECG income_statement (annual, 2025-12-31) — Diluted EPS: 3.95
ECG income_statement (quarterly, 2025-12-31) — Diluted EPS: 1.08
ECG income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: 201770000.00
ECG income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: 55278000.00
ECG income_statement (annual, 2025-12-31) — EBIT: 279262000.00
ECG income_statement (quarterly, 2025-12-31) — EBIT: 74312000.00
ECG income_statement (annual, 2025-12-31) — EBITDA: 308062000.00
ECG income_statement (quarterly, 2025-12-31) — EBITDA: 81803000.00
ECG income_statement (annual, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 16270000.00
ECG income_statement (quarterly, 2025-12-31) — Earnings From Equity Interest Net Of Tax: 4693000.00
ECG cash_flow (annual, 2025-12-31) — Earnings Losses From Equity Investments: -5186000.00
ECG cash_flow (quarterly, 2025-12-31) — Earnings Losses From Equity Investments: -1095000.00
ECG cash_flow (annual, 2025-12-31) — End Cash Position: 170500000.00
ECG cash_flow (quarterly, 2025-12-31) — End Cash Position: 170500000.00
ECG cash_flow (annual, 2025-12-31) — Financing Cash Flow: -15588000.00
ECG cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: -3750000.00
ECG balance_sheet (annual, 2025-12-31) — Finished Goods: 27057000.00
ECG balance_sheet (quarterly, 2025-12-31) — Finished Goods: 27057000.00
ECG cash_flow (annual, 2025-12-31) — Free Cash Flow: 90009000.00
ECG cash_flow (quarterly, 2025-12-31) — Free Cash Flow: 23488000.00
ECG balance_sheet (annual, 2025-12-31) — Goodwill: 143224000.00
ECG balance_sheet (quarterly, 2025-12-31) — Goodwill: 143224000.00
ECG balance_sheet (annual, 2025-12-31) — Goodwill And Other Intangible Assets: 143224000.00
ECG balance_sheet (quarterly, 2025-12-31) — Goodwill And Other Intangible Assets: 143224000.00
ECG balance_sheet (annual, 2025-12-31) — Gross PPE: 432117000.00
ECG balance_sheet (quarterly, 2025-12-31) — Gross PPE: 432117000.00
ECG income_statement (annual, 2025-12-31) — Gross Profit: 454088000.00
ECG income_statement (quarterly, 2025-12-31) — Gross Profit: 117504000.00
ECG cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 77819000.00
ECG cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 31574000.00
ECG income_statement (annual, 2025-12-31) — Interest Expense: 21451000.00
ECG income_statement (quarterly, 2025-12-31) — Interest Expense: 5014000.00
ECG income_statement (annual, 2025-12-31) — Interest Expense Non Operating: 21451000.00
ECG income_statement (quarterly, 2025-12-31) — Interest Expense Non Operating: 5014000.00
ECG income_statement (annual, 2025-12-31) — Interest Income: 4573000.00
ECG income_statement (quarterly, 2025-12-31) — Interest Income: 1715000.00
ECG income_statement (annual, 2025-12-31) — Interest Income Non Operating: 4573000.00
ECG income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 1715000.00
ECG cash_flow (annual, 2025-12-31) — Interest Paid Supplemental Data: 19709000.00
ECG cash_flow (quarterly, 2025-12-31) — Interest Paid Supplemental Data: 4626000.00
ECG balance_sheet (annual, 2025-12-31) — Inventories Adjustments Allowances: -587000.00
ECG balance_sheet (quarterly, 2025-12-31) — Inventories Adjustments Allowances: -587000.00
ECG balance_sheet (annual, 2025-12-31) — Inventory: 45271000.00
ECG balance_sheet (quarterly, 2025-12-31) — Inventory: 45271000.00
ECG balance_sheet (annual, 2025-12-31) — Invested Capital: 911367000.00
ECG balance_sheet (quarterly, 2025-12-31) — Invested Capital: 911367000.00
ECG cash_flow (annual, 2025-12-31) — Investing Cash Flow: -56769000.00
ECG cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -23122000.00
ECG balance_sheet (annual, 2025-12-31) — Investments And Advances: 27082000.00
ECG balance_sheet (quarterly, 2025-12-31) — Investments And Advances: 27082000.00
ECG cash_flow (annual, 2025-12-31) — Issuance Of Debt: 0.00
ECG balance_sheet (annual, 2025-12-31) — Land And Improvements: 10187000.00
ECG balance_sheet (quarterly, 2025-12-31) — Land And Improvements: 10187000.00
ECG balance_sheet (annual, 2025-12-31) — Long Term Capital Lease Obligation: 56634000.00
ECG balance_sheet (quarterly, 2025-12-31) — Long Term Capital Lease Obligation: 56634000.00
ECG balance_sheet (annual, 2025-12-31) — Long Term Debt: 266549000.00
ECG balance_sheet (quarterly, 2025-12-31) — Long Term Debt: 266549000.00
ECG balance_sheet (annual, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 323183000.00
ECG balance_sheet (quarterly, 2025-12-31) — Long Term Debt And Capital Lease Obligation: 323183000.00
ECG cash_flow (annual, 2025-12-31) — Long Term Debt Issuance: 0.00
ECG cash_flow (annual, 2025-12-31) — Long Term Debt Payments: -15000000.00
ECG cash_flow (quarterly, 2025-12-31) — Long Term Debt Payments: -3750000.00
ECG balance_sheet (annual, 2025-12-31) — Machinery Furniture Equipment: 258523000.00
ECG balance_sheet (quarterly, 2025-12-31) — Machinery Furniture Equipment: 258523000.00
ECG balance_sheet (annual, 2025-12-31) — Net Debt: 111049000.00
ECG balance_sheet (quarterly, 2025-12-31) — Net Debt: 111049000.00
ECG income_statement (annual, 2025-12-31) — Net Income: 201770000.00
ECG income_statement (quarterly, 2025-12-31) — Net Income: 55278000.00
ECG income_statement (annual, 2025-12-31) — Net Income Common Stockholders: 201770000.00
ECG income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: 55278000.00
ECG income_statement (annual, 2025-12-31) — Net Income Continuous Operations: 201770000.00
ECG income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: 55278000.00
ECG income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 201770000.00
ECG income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: 55278000.00
ECG income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 201770000.00
ECG income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: 55278000.00
ECG cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: 201770000.00
ECG cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: 55278000.00
ECG income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: 201770000.00
ECG income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: 55278000.00
ECG income_statement (annual, 2025-12-31) — Net Interest Income: -16878000.00
ECG income_statement (quarterly, 2025-12-31) — Net Interest Income: -3299000.00
ECG cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: -2078000.00
ECG cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: -107000.00
ECG cash_flow (annual, 2025-12-31) — Net Issuance Payments Of Debt: -15000000.00
ECG cash_flow (quarterly, 2025-12-31) — Net Issuance Payments Of Debt: -3750000.00
ECG cash_flow (annual, 2025-12-31) — Net Long Term Debt Issuance: -15000000.00
ECG cash_flow (quarterly, 2025-12-31) — Net Long Term Debt Issuance: -3750000.00
ECG income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: -16878000.00
ECG income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: -3299000.00
ECG cash_flow (annual, 2025-12-31) — Net Other Financing Charges: -588000.00
ECG cash_flow (quarterly, 2025-12-31) — Net Other Financing Charges: 0.00
ECG cash_flow (annual, 2025-12-31) — Net Other Investing Changes: 2174000.00
ECG cash_flow (quarterly, 2025-12-31) — Net Other Investing Changes: 0.00
ECG balance_sheet (annual, 2025-12-31) — Net PPE: 257203000.00
ECG balance_sheet (quarterly, 2025-12-31) — Net PPE: 257203000.00
ECG cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: 9971000.00
ECG cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: 1702000.00
ECG cash_flow (annual, 2025-12-31) — Net Short Term Debt Issuance: 0.00
ECG balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 486594000.00
ECG balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 486594000.00
ECG balance_sheet (annual, 2025-12-31) — Non Current Deferred Liabilities: 14869000.00
ECG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Liabilities: 14869000.00
ECG balance_sheet (annual, 2025-12-31) — Non Current Deferred Taxes Liabilities: 14869000.00
ECG balance_sheet (quarterly, 2025-12-31) — Non Current Deferred Taxes Liabilities: 14869000.00
ECG income_statement (annual, 2025-12-31) — Normalized EBITDA: 308062000.00
ECG income_statement (quarterly, 2025-12-31) — Normalized EBITDA: 81803000.00
ECG income_statement (annual, 2025-12-31) — Normalized Income: 201770000.00
ECG income_statement (quarterly, 2025-12-31) — Normalized Income: 55278000.00
ECG cash_flow (annual, 2025-12-31) — Operating Cash Flow: 156845000.00
ECG cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: 48205000.00
ECG cash_flow (annual, 2025-12-31) — Operating Gains Losses: -11162000.00
ECG cash_flow (quarterly, 2025-12-31) — Operating Gains Losses: -1924000.00
ECG income_statement (annual, 2025-12-31) — Operating Income: 264750000.00
ECG income_statement (quarterly, 2025-12-31) — Operating Income: 68878000.00
ECG income_statement (annual, 2025-12-31) — Operating Revenue: 3769193000.00
ECG income_statement (quarterly, 2025-12-31) — Operating Revenue: 1019243000.00
ECG balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 51006719.00
ECG balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 51006719.00
ECG balance_sheet (annual, 2025-12-31) — Other Current Assets: 55015000.00
ECG balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 55015000.00
ECG balance_sheet (annual, 2025-12-31) — Other Current Borrowings: 15000000.00
ECG balance_sheet (quarterly, 2025-12-31) — Other Current Borrowings: 15000000.00
ECG income_statement (annual, 2025-12-31) — Other Income Expense: 9939000.00
ECG income_statement (quarterly, 2025-12-31) — Other Income Expense: 3719000.00
ECG cash_flow (annual, 2025-12-31) — Other Non Cash Items: 1576000.00
ECG cash_flow (quarterly, 2025-12-31) — Other Non Cash Items: 394000.00
ECG balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 4841000.00
ECG balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 4841000.00
ECG balance_sheet (annual, 2025-12-31) — Other Non Current Liabilities: 24671000.00
ECG balance_sheet (quarterly, 2025-12-31) — Other Non Current Liabilities: 24671000.00
ECG income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 9939000.00
ECG income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 3719000.00
ECG balance_sheet (annual, 2025-12-31) — Other Properties: 98290000.00
ECG balance_sheet (quarterly, 2025-12-31) — Other Properties: 98290000.00
ECG balance_sheet (annual, 2025-12-31) — Other Receivables: 261867000.00
ECG balance_sheet (quarterly, 2025-12-31) — Other Receivables: 261867000.00
ECG balance_sheet (annual, 2025-12-31) — Payables: 232747000.00
ECG balance_sheet (quarterly, 2025-12-31) — Payables: 232747000.00
ECG balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 295214000.00
ECG balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 295214000.00
ECG balance_sheet (annual, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 86960000.00
ECG balance_sheet (quarterly, 2025-12-31) — Pensionand Other Post Retirement Benefit Plans Current: 86960000.00
ECG balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
ECG balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
ECG income_statement (annual, 2025-12-31) — Pretax Income: 257811000.00
ECG income_statement (quarterly, 2025-12-31) — Pretax Income: 69298000.00
ECG balance_sheet (annual, 2025-12-31) — Properties: 0.00
ECG balance_sheet (quarterly, 2025-12-31) — Properties: 0.00
ECG cash_flow (annual, 2025-12-31) — Provisionand Write Offof Assets: 636000.00
ECG cash_flow (quarterly, 2025-12-31) — Provisionand Write Offof Assets: 2147000.00
ECG balance_sheet (annual, 2025-12-31) — Raw Materials: 15571000.00
ECG balance_sheet (quarterly, 2025-12-31) — Raw Materials: 15571000.00
ECG balance_sheet (annual, 2025-12-31) — Receivables: 1025595000.00
ECG balance_sheet (quarterly, 2025-12-31) — Receivables: 1025595000.00
ECG balance_sheet (annual, 2025-12-31) — Receivables Adjustments Allowances: -5282000.00
ECG balance_sheet (quarterly, 2025-12-31) — Receivables Adjustments Allowances: -5282000.00
ECG income_statement (annual, 2025-12-31) — Reconciled Cost Of Revenue: 3292299000.00
ECG income_statement (quarterly, 2025-12-31) — Reconciled Cost Of Revenue: 893968000.00
ECG income_statement (annual, 2025-12-31) — Reconciled Depreciation: 28800000.00
ECG income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 7491000.00
ECG cash_flow (annual, 2025-12-31) — Repayment Of Debt: -15000000.00
ECG cash_flow (quarterly, 2025-12-31) — Repayment Of Debt: -3750000.00
ECG balance_sheet (annual, 2025-12-31) — Retained Earnings: 485742000.00
ECG balance_sheet (quarterly, 2025-12-31) — Retained Earnings: 485742000.00
ECG cash_flow (annual, 2025-12-31) — Sale Of PPE: 9971000.00
ECG cash_flow (quarterly, 2025-12-31) — Sale Of PPE: 1702000.00
ECG income_statement (annual, 2025-12-31) — Selling General And Administration: 189338000.00
ECG income_statement (quarterly, 2025-12-31) — Selling General And Administration: 48626000.00
ECG balance_sheet (annual, 2025-12-31) — Share Issued: 51006719.00
ECG balance_sheet (quarterly, 2025-12-31) — Share Issued: 51006719.00
ECG cash_flow (annual, 2025-12-31) — Short Term Debt Payments: 0.00